Serum-derived piR-hsa-164586 of extracellular vesicles as a novel biomarker for early diagnosis of non-small cell lung cancer

Serum-derived piR-hsa-164586 of extracellular vesicles as a novel biomarker for early diagnosis of non-small cell lung cancer

Non-small cell lung cancer (NSCLC) is a major cause of death in those with malignant tumors. To achieve the early diagnosis of NSCLC, we investigated serum-derived Piwi-interacting RNA (piRNA) of extracellular vesicles to filter diagnostic biomarkers for NSCLC. High-throughput sequencing from cancer...

Full description

Bibliographic Details
Main Authors: Yanli Li, Yanhan Dong, Shupeng Zhao, Jinning Gao, Xiaodan Hao, Zibo Wang, Meng Li, Mengyuan Wang, Yiming Liu, Xiaoling Yu, Wenhua Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
serum
extracellular vesicles
piRNA
liquid biopsy
early diagnosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.850363/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.850363/full

Similar Items